Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry.

JACC. Advances·2026
Same author

Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: The BATMAN Registry.

JACC. Cardiovascular interventions·2026
Same author

Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR: Results From the LOFTER-TAVR Registry.

JACC. Cardiovascular interventions·2026
Same author

Comparison of Leaflet Modification Techniques for TAV-in-TAV: Insights From Bench Testing.

JACC. Cardiovascular interventions·2026
Same author

Leaflet Modification for Redo-TAVR: Impact of Valve Type, Expansion, and Failure Mode-A Bench Study.

JACC. Cardiovascular interventions·2026
Same author

Commissural Misalignment-Mediated Sinus Sequestration Following Balloon-Augmented BASILICA During Redo-TAVR.

JACC. Cardiovascular interventions·2026

Related Experiment Video

Updated: May 11, 2025

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

933

Even aortic insufficiency can be treated percutaneously: right?

Nicolò Azzola Guicciardi1, Alessandro Beneduce1, Francesco Maisano1

  • 1Department of Cardiac Surgery, Valve Center-IRCCS San Raffaele Hospital, Milan, Italy.

European Heart Journal Supplements : Journal of the European Society of Cardiology
|April 18, 2025
PubMed
Summary

Transcatheter aortic valve implantation (TAVI) offers a promising alternative for patients with severe aortic insufficiency (AI) who are high surgical risks. Newer devices show improved safety and efficacy, though pacemaker implantation remains a concern.

Keywords:
Aortic regurgitationInnovationTAVR

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.2K

Related Experiment Videos

Last Updated: May 11, 2025

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

933
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.2K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Severe aortic insufficiency (AI) poses significant risks, particularly for elderly patients unsuitable for traditional surgery.
  • Transcatheter aortic valve implantation (TAVI) has transformed aortic stenosis treatment but faces challenges in AI due to unique patient anatomy.

Purpose of the Study:

  • To review the evolution of transcatheter treatments for aortic insufficiency.
  • To highlight advancements in TAVI devices for AI and assess their clinical outcomes.

Main Methods:

  • Review of current literature on transcatheter aortic valve implantation for aortic insufficiency.
  • Analysis of first-generation and newer TAVI devices (e.g., JenaValve, J-Valve) in AI patients.
  • Evaluation of procedural success, safety, and limitations.

Main Results:

  • Newer TAVI devices demonstrate encouraging results in reducing residual AI and improving safety for high-risk patients.
  • Challenges persist, including a high rate of pacemaker implantation and limited long-term data.
  • Technological progress is making TAVI a viable option for selected AI patients.

Conclusions:

  • Transcatheter aortic valve implantation is an evolving and promising option for select patients with severe AI and high surgical risk.
  • Continued research and high-volume center expertise are crucial for optimizing TAVI outcomes in AI.
  • Further long-term randomized trials are needed to fully establish the role of TAVI in AI management.